Dr. James Garner, MA, MBA, MBBS, BSc (Hons), SAFin., has been the Chief Executive Officer of Novogen Limited since February 1, 2016 and its Executive Director since February 5, 2016. Dr. Garner has been Managing Director of Novogen Limited since February 5, 2016. He serves as Head of the Unit Development Office, AP R&D with Sanofi and is based in Singapore. After qualifying in medicine at Imperial College in London, he spent several years as a practicing clinician in the UK and Australia before joining Bain & Company, a global management consulting company in 2002. He subsequently worked with Biogen and Progen Pharmaceuticals in Australia and with Quintiles, an international clinical research organisation in Singapore. He has broad experience in drug development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector. He served as Vice President of Medical and Clinical Affairs of Progen Pharmaceuticals Limited from January 29, 2007 to November 2008. Dr. Garner served as Medical Affairs Manager at Biogen Idec for the Asia-Pacific region. At Biogen Idec, he drove the commercial launch of a number of novel biologic therapies in nine Asian countries, and also managed regional clinical research and business development activities. Since 2009, he served as Regional Vice President for Takeda Pharmaceutical Company with overall responsibility for all clinical development activities and registration of new chemical entities in the Asian region (excluding Japan), and served as General Manger. Mr. Garner served as a Corporate Strategy Consultant of Bain & Company in Sydney. He began his career practicing medicine at a number of hospitals throughout the United Kingdom and Australia. His previous responsibilities have included leading non-clinical safety and efficacy, phase I-IV clinical trials, product registration, reimbursement, medical marketing and business development. He is a Young Fellow of the Royal Society of Medicine (UK) and a member of the Australian Pharmaceutical Physicians Association. He holds a Bachelor of Sciences (with First Class Honors) from University College, London, and a Master of Arts and a Master of Business Administration from the University of Queensland and a Graduate Certificate in Applied Finance and Investment from the Financial Services Institute of Australasia.